https://www.prnewswire.com/news-releases/biomarin-extends-gene-therapy-leadership-with-dinaqor-in-a-preclinical-collaboration-and-license-agreement-to-develop-gene-therapies-for-rare-genetic-cardiomyopathies-301051582.html
BioMarin Extends Gene Therapy Leadership with DiNAQOR in a Preclinical Collaboration and License...
/PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that the company has entered into a preclinical collaboration and license...